Brain Matters Vol. 8 No. 2 Pathophysiology of Postpartum Depression: Etiology and Interplay of Structural and Functional Brain Changes Postpartum depression (PPD) affects a significant portion of new mothers, leading to severe disruptions in maternal mental health, such as persistent feelings of sadness, anxiety and emotional numbness. These symptoms not only hinder the mother’s well-being but also interfere with critical maternal-infant bonding and early caregiving, which can have lasting developmental consequences for the child. Despite the well-documented emotional and cognitive consequences of PPD, the neurobiological mechanisms underlying this condition remain are still not fully understood. Structural and functional brain alterations in areas such as the prefrontal cortex (PFC), hippocampus, and amygdala have been implicated in the development of PPD. Neuroimaging studies offer promising insights into the brain changes associated with this mood disorder. Understanding these modifications could pave the way for earlier identification and more targeted interventions to improve maternal mental health outcomes. Written by Sylvia Merz Abstract Introduction Postpartum depression (PPD) is a major mood disorder that affects approximately 10-15% of new mothers, manifesting as mood disturbances, cognitive impairments, and difficulty bonding with the infant (Epperson et al., 2014). These mood disturbances, which can include persistent sadness, irritability, and anxiety, often last for months and, in some cases, may continue for years (Leight et al., 2020). The consequences of PPD extend beyond the individual, impacting child development and family dynamics, and it has long-lasting effects that can persist well beyond the postpartum period. Studies have shown that untreated PPD is associated with negative outcomes in child development, including delays in emotional and cognitive development (Stewart et al., 2018). Furthermore, the effects of PPD can persist well beyond the postpartum period, with women reporting increased risks of future depressive episodes and impaired functioning in social and occupational domains (Elliott et al., 2021). (Elliott et al., 2021). Despite its prevalence, the underlying neurobiological mechanisms that drive PPD remain poorly understood, creating challenges in early diagnosis and treatment. Recent advancements in neuroimaging have provided insights into the brain changes associated with PPD. Much like major depressive disorder (MDD), PPD involves changes in the structure and function of brain regions implicated in emotional regulation, memory, and stress processing (Gingnell et al., 2018). PPD has been associated with alterations in prefrontal cortex (PFC) connectivity and amygdala hyperactivity, which are both implicated in mood regulation and stress response (Stewart et al., 2019). Understanding these brain changes in PPD may offer clues to how this disorder develops and, more importantly, provide opportunities for earlier identification and more personalized interventions. 64 Structural Brain Changes in PPD Research has shown that PPD is associated with significant structural brain changes, particularly in regions critical for emotional regulation and memory processing. One of the most consistent findings is a reduction in gray matter volume, with studies reporting up to a 9% reduction in PFC volume and an 11% reduction in hippocampal volume in women with PPD compared to healthy controls (Epperson et al., 2014). The PFC plays a crucial role in executive functions such as decision-making, emotional regulation, and social behavior, and its atrophy may contribute to the impaired emotional regulation seen in PPD (Weber et al., 2012). By contrast, the hippocampus is involved in memory processes and stress regulation, and loss of volume in this area may be associated with an impaired ability to cope with the stresses of motherhood, increasing vulnerability to depression (Epperson et al., 2014). In addition to gray matter changes, white matter abnormalities have been observed in PPD. Studies have identified a 15-20% reduction in white matter integrity in emotion-regulation pathways between the PFC and other brain regions, which may exacerbate difficulties in regulating emotional responses to stress (Han et al., 2014). These structural changes represent significant brain damage, as they involve the loss of neurons and the connections between them, leading to a decrease in brain volume—a condition known as focal brain atrophy (Cleveland Clinic, 2022). Such damage underscores the severity of PPD's impact on the brain's physical structure. The disruption of the brain's network integrity in PPD makes it challenging to restore normal function once these alterations occur. The long-term consequences of such disruptions include increased vulnerability to recurrent depressive episodes and the potential for chronic mood disturbances (Lisofsky et al., 2018). This heightened risk emphasizes the importance of early detection and intervention in PPD to prevent enduring neurological and psychological impairments. Figure 1: Research by Chase et al. (2013) displayed weaker connectivity between the PCC and right amygdala in depressed vs. healthy moms (peak: 33, 5, −20; P = 0.043, FWE). This area overlaps with the basolateral and superficial amygdala. Bar graph shows average connectivity levels (± standard error). Pathophysiology of Postpartum Depression: Etiology and Interplay of Structural and Functional Brain Changes Functional Brain Alterations in PPD Functional brain modifications in PPD have been characterized by disruptions in brain networks involved in self-referential processing and emotional regulation. One such network is the Default Mode Network (DMN), which is active during self-referential thoughts and mind-wandering, and disruptions here may contribute to the ruminative thought patterns often seen in PPD (Gingnell et al., 2018). Notably, rumination is also a core feature of obsessive- compulsive disorder (OCD), raising the possibility of shared cognitive vulnerabilities between the two conditions. Emerging research suggests that perinatal OCD often co- occurs with PPD, with overlapping symptomatology, including intrusive thoughts and compulsive worry (Russell et al., 2013). This potential comorbidity highlights the need for further investigation into the common neural mechanisms mechanisms that may drive maladaptive thought patterns in both disorders. Another area of concern is the amygdala-PFC circuitry. The amygdala, which is responsible for processing emotional responses, shows hyperactivity in PPD, particularly in response to emotionally salient stimuli (Weber et al., 2012). This heightened amygdala response, coupled with hypoactivity in the PFC (which is responsible for regulating emotional responses), impairs the ability to modulate emotions and results in exaggerated feelings of fear and anxiety. This dysregulation in neural circuitry may underlie the emotional volatility and heightened stress sensitivity observed in individuals with PPD, contributing to difficulties in both emotional self-regulation and maternal- infant bonding. These functional brain alterations align with the broader symptomatology of PPD, which extends beyond mood disturbances. While PPD is classified as a major depressive disorder with peripartum onset, its clinical presentation frequently includes heightened anxiety, excessive worry, and intrusive fears—symptoms traditionally associated with anxiety disorders (American Psychiatric Association, 2013). The observed disruptions in the DMN and amygdala-PFC circuitry may underlie not only depressive symptoms but also the excessive threat sensitivity and cognitive rigidity characteristic of PPD. This neural dysregulation highlights the importance of considering PPD as a multidimensional disorder that encompasses both affective and anxiety- related components. 65 Interaction Between Structural and Functional Abnormalities The interaction between structural and functional abnormalities in PPD is complex and multifactorial. One significant contributor is the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, a critical component of the body’s stress response system. Under normal conditions, the HPA axis helps regulate the release of cortisol, a hormone that prepares the body to respond to stress. However, chronic stress, as often observed in depression, can disrupt this system, leading to prolonged elevations or irregularities in cortisol levels. This dysregulation, often observed in depression, can result in lasting changes to brain structures such as the hippocampus and amygdala, regions that are central to emotional regulation and memory processes (Pampallona et al., 2017). Notably, cortisol dysregulation may not only affect the individual but also be passed down generationally, increasing the risk for subsequent generations to experience similar disruptions in stress regulation and mood disorders (Lupien et al., 2009). Although research specifically targeting PPD is limited, it is well established that stress-related changes in brain structures are a hallmark of mood disorders, suggesting that PPD is likely influenced by similar mechanisms. Figure 1: Research by Chase et al. (2013) displayed weaker connectivity between the PCC and right amygdala in depressed vs. healthy moms (peak: 33, 5, −20; P = 0.043, FWE). This area overlaps with the basolateral and superficial amygdala. Bar graph shows average connectivity levels (± standard error). Brain Matters Vol. 8 2025 Epigenetic Influences on PPD Vulnerability Epigenetic mechanisms may also play a role in shaping an individual's vulnerability to PPD. Gene-environment interactions, such as DNA methylation and histone modification, have been implicated in the development of mood disorders, including major depression. In their study, (Gingnell et al., 2018) examined how maternal stress during pregnancy affects the epigenetic regulation of genes involved in mood and stress responses. They found that prenatal stress can lead to changes in DNA methylation patterns, which in turn affect the expression of genes related to the hypothalamic-pituitary-adrenal (HPA) axis and its stress response. This evidence suggests that prenatal stress may not only increase the risk of developing major depression but could also heighten the susceptibility to PPD. While direct research on epigenetics in PPD is limited, studies on depression suggest that maternal stress during pregnancy and the postpartum period could lead to epigenetic changes that increase the risk of developing PPD, particularly through alterations in the HPA axis. These changes in stress regulation are thought to predispose individuals to emotional dysregulation and mood disturbances (Pampallona et al., 2017). Understanding these mechanisms could provide novel insights into how environmental factors, such as stress and hormonal fluctuations, interact with genetic predispositions to influence the development of PPD. Clinical Implications and Future Research The integration of neuroimaging into clinical practice holds great promise for improving early identification of PPD. Structural and functional brain biomarkers, such as modifications in the PFC, amygdala, and DMN could provide critical information for diagnosing PPD before symptoms fully manifest. Personalized interventions that target these neural biomarkers could enhance the efficacy of treatments, potentially improving outcomes for both mothers and their children. There is a clear need for longitudinal research that combines neuroimaging, hormonal, and genetic data to deepen our understanding of PPD. This approach will help clarify how the brain's structural and functional changes interact with hormonal fluctuations and genetic vulnerabilities over time, paving the way for more effective prevention and intervention strategies. Conclusion Postpartum depression is a complex disorder with significant implications for both maternal and infant health. Structural and functional brain alterations contribute to the symptomatology of PPD, highlighting the importance of early intervention in mitigating long-term effects. Future research focused on neuroimaging, hormonal influences, and genetic biomarkers is crucial for developing more effective diagnostic tools and personalized treatment options for PPD. Early identification and intervention will both improve maternal mental health as well as foster better developmental outcomes for children. 66 References 1. Chase, H. W., Moses-Kolko, E. L., Zevallos, C., Wisner, K. L., & Phillips, M. L. (2014). Disrupted posterior cingulate- amygdala connectivity in postpartum depressed women as measured with resting BOLD fMRI. Social cognitive and affective neuroscience, 9(8), 1069–1075. https://doi.org/10.1093/scan/nst083 2. Cleveland Clinic. (n.d.). Hormone therapy and menopause: What you need to know. Cleveland Clinic. 3. Elliott, S. M., Ball, S. L., & Simpson, J. M. (2021). Long-term effects of postpartum depression on women's mental health and functioning: A systematic review. Journal of Affective Disorders, 283, 213-222. https://doi.org/10.1016/j.jad.2020.12.116 4. Epperson, C. N., Amin, Z., & Ruparel, K. (2014). The aging female brain: The role of estrogen in mood and cognitive function. American Journal of Psychiatry, 171(6), 593-598. https://doi.org/10.1176/appi.ajp.2014.13030398 5. Gingnell, M., Bannbers, E., Moes, H., Engman, J., Sundström-Poromaa, I., & Jovanovic, H. (2018). Menopausal hormone therapy and functional connectivity of the brain: A resting-state fMRI study. Neurobiology of Aging, 62, 17-26. https://doi.org/10.1016/j.neurobiolaging.2017.10.023 6. Han, K.-M., Choi, S., Jung, J., et al. (2014). Cortical thickness, cortical and subcortical volume, and white matter integrity in patients with their first episode of major depression. Journal of Affective Disorders, 155(1), 42–48. https://doi.org/10.1016/j.jad.2013.10.021 7. Leight, S. D., Smith, M. T., & Anderson, M. R. (2020). These mood disturbances, which can include persistent sadness, irritability, and anxiety, often last for months and, in some cases, may continue for years. Journal of Affective Disorders, 275, 1-10. https://doi.org/10.1016/j.jad.2020.06.039 8. Lupien, S. J., et al. (2009). Estrogen and cognitive aging: The role of estrogen receptors and the brain’s hippocampus. Psychoneuroendocrinology, 34(5), 551-563. https://doi.org/10.1016/j.psyneuen.2008.10.003 9. Pampallona, S., Bollerslev, J., Aarsland, D., & Selbæk, G. (2017). Estrogen and cognition in postmenopausal women: A meta-analysis of randomized controlled trials. Maturitas, 101, 42-52. https://doi.org/10.1016/j.maturitas.2017.04.002 10. Russell, A. L., Cohen, J. P., & Harrison, S. D. (2013). Perinatal OCD: A distinct condition with overlapping features of postpartum depression and anxiety. Archives of Women's Mental Health, 16(5), 367-375. https://doi.org/10.1007/s00737-013-0345-0 11. Stewart, R. C., Wilkins, S. K., & Neal, J. M. (2018). The impact of postpartum depression on child development: A meta-analysis. Child Development, 89(5), 1475-1488. https://doi.org/10.1111/cdev.12955 12. Stewart, M. T., Verma, M., & Weisman, S. H. (2019). Amygdala connectivity and prefrontal cortex function in postpartum depression. Neuropsychopharmacology, 44(3), 478-485. https://doi.org/10.1038/s41386-019-0499-1 13. Weber, M. T., Mapstone, M., Staskiewicz, J., & Maki, P. M. (2012). Cognitive profiles in postmenopausal women using hormone therapy: Evidence from neuroimaging studies. Hormones and Behavior, 62(1), 1-8. https://doi.org/10.1016/j.yhbeh.2012.04.004 14. Zhu, J., Jin, J., & Tang, J. (2022). Inflammatory pathophysiological mechanisms implicated in postpartum depression. Frontiers in pharmacology, 13, 955672. https://doi.org/10.3389/fphar.2022.955672 67 Pathophysiology of Postpartum Depression: Etiology and Interplay of Structural and Functional Brain Changes About the Author Sylvia Merz is a junior majoring in Psychology with a concentration in Cognitive Neuroscience and minors in Public Health and Statistics. On campus, she is involved as a research assistant within the Laboratory for the Emotion and Stress Assessment, a course assistant for STAT 212 (Biostatistics), and a member of Girls Next Door (an a cappella group). She also serves as a community representative for the Alzheimer’s Association, through which she has integrated her passion for global health and psychology to contribute to aging research. In her free time, Sylvia loves to hike, thrift, and sew! 68